Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Akebia Therapeutics, Inc. AKBA NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
45/100
2/7 Pass
SharesGrow Intrinsic Value
$331.69
+21299.4%
Analyst Price Target
$4.00
+158.1%

Akebia Therapeutics, Inc. (AKBA) has 10 identified peers for comparison in the Healthcare sector. Peers include AVRO, CDTX, CWBR, ELEV, ENVB, HEPA and others.

AKBA has a market capitalization of $415.21M, compared to an average peer market cap of $596.96M.

People Also View

CDTX
CDTX
Cidara Therapeutics, Inc.
$221.38
+0.00%
 PLX
PLX
Protalix BioTherapeutics, Inc.
$2.38
+0.85%
 MCRB
MCRB
Seres Therapeutics, Inc.
$8.84
+2.67%
 XFOR
XFOR
X4 Pharmaceuticals, Inc.
$4.33
+3.10%
 ELEV
ELEV
Elevation Oncology, Inc.
$0.37
-2.12%
 AVRO
AVRO
AVROBIO, Inc.
$1.40
-1.41%
 ENVB
ENVB
Enveric Biosciences, Inc.
$2.03
+4.10%
 CWBR
CWBR
CohBar, Inc.
$0.41
+0.00%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message